|
Aigner A.
Cellular delivery in vivo of siRNA-based therapeutics
Curr Pharm Design 14
(2008) 3603-19
Baumann
F, Maus-Körholz C, Clauss
D, Borrmann
S, Giannis A, Merkel N, Körholz D, Preiss R:
Determination of terephthalic acid isopropylamide in urine with a
liquid chromatography/mass spectrometry (LC/MS) method
J Clin Lab Anal 22(1) 2008 21-28
Höbel
S, Prinz R, Malek A, Urban-Klein B, Sitterberg J, Bakowsky U, Czubayko
F, Aigner A.
Polyethylenimine
(PEI F25-LMW) allows storage of frozen PEI/DNA and PEI/siRNA complexes
as fully active ready-to-use reagents in gene targeting and delivery.
Eur J Pharm Biopharm 70
(2008) 29-41
Malek A,
Czubayko F, Aigner A
PEG grafting of polyethylenimine (PEI) exerts different
effects on DNA transfection and siRNA-induced gene targeting efficacy.
J Drug Target 16(2)
(2008) 124-139
Knüpfer H, Preiss R:
sIL-6R: more than an agonist?
Immunol Cell Biol 86(1) 2008 87-91
Ludewig R:
Leitsymptom Handschriftveränderungen - Teil IV
Ärzteblatt Sachsen 19(1) 2008 26-28
Malek A, Bakhidze
E, Noske A, Sers C, Aigner A, Schäfer R, Tchernitsa O.
HMGA2 gene is a promising target for ovarian cancer
silencing therapy
Int J Cancer 123(2)
(2008) 348-356
Michael C, Teichert J, Preiss R:
Determination of voriconazole in human plasma and saliva using
high-performance liquid chromatography with fluorescence detection.
J Chromatogr B Analyt Technol Biomed Life Sci 865(1-2)
2008 74-80
Schlenska-Lange A, Knüpfer H, Lange
TJ, Kiess
W, Knüpfer M;
Cell proliferation and migration in glioblastoma multiforme cell lines
are influenced by insulin-like growth factor I in vitro.
Anticancer Res 28(2A) 2008 1055-1060
von Haussen J,
Koczulla R, Shaykhiev R, Herr C, Pinkenburg O, Reimer D, Wiewrodt R,
Biesterfeld S, Aigner A, Czubayko F, Bals R.
The host defence peptide LL-37/hCap-18 is a growth
factor for lung cancer cells.
Lung Cancer 59(1)
(2008) 12-23
|